Illumina Ventures
Status
ACTIVE
Global HQ
California, United States
Countries of investment
- USA
- United Kingdom
- France
- Ireland
Investment stages
- Series A
Industries
- Health Tech
- Biotechnology
- AI
- Data science
About
Illumina Ventures is a genomics-focused firm investing in pioneering tools, therapeutics, and diagnostics to advance precision medicine.
Illumina Ventures is a genomics-focused firm investing in pioneering tools, therapeutics, and diagnostics to advance precision medicine.
Investment Thesis
They invest globally in pioneering companies in genomics and precision health, in markets such as life science tools, clinical diagnostics, therapeutics, digital health, and other areas impacted by genomics.
Manager's Experience
Leveraging extensive expertise in venture capital, the fund manager has successfully executed over 50 investments across sectors such as technology, healthcare, and consumer products. With a strong presence in North America and Europe, their strategic style emphasizes a data-driven approach, targeting early to growth-stage companies. Notable exits include several high-profile IPOs and mergers, showcasing a robust track record of value creation. Their operator-first philosophy ensures a hands-on involvement in portfolio companies, driving sustainable growth and innovation.
Team
Wouter Meuleman
Omer Ayfer
Donal Delaney
Cindy Munn
Wouter Meuleman
Thomas Willis